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Abstract
Background: Sialic acid is a deoxy uronic acid with a skeleton of nine carbons which is mostly
found on cell surface in animals. This sialic acid on cell surface performs various biological functions
by acting as a receptor for microorganisms, viruses, toxins, and hormones; by masking receptors;
and by regulating the immune system. In order to synthesize an artificial sialoglycoprotein, we
developed a large-scale production of rat α2,6-sialyltransferase (ST6Gal1). The ST6Gal1 was
expressed in fifth instar silkworm larval hemolymph using recombinant both cysteine protease- and
chitinase-deficient Bombyx mori nucleopolyhedrovirus (BmNPV-CP--Chi-) bacmid. The expressed
ST6Gal1 was purified, characterized and used for sialylation of asialoglycopolypeptide. We tested
the inhibitory effect of the synthesized α2,6-sialoglycopolypeptide  on hemagglutination by
Sambucus nigra (SNA) lectin.
Results: FLAG-tagged recombinant ST6Gal1 was expressed efficiently and purified by precipitation
with ammonium sulphate followed by affinity chromatography on an anti-FLAG M2 column,
generating 2.2 mg purified fusion protein from only 11 silkworm larvae, with a recovery yield of
64%. The purified ST6Gal1 was characterized and its N-glycan patterns were found to be
approximately paucimannosidic type by HPLC mapping method. Fluorescently-labelled N-
acetyllactosamine (LacNAc) glycoside containing dansyl group was synthesized chemo-
enzymatically as high-sensitivity acceptor substrate for ST6Gal1. The acceptor substrate specificity
of the enzyme was similar to that of rat liver ST6Gal1. The fluorescent glycoside is useful as a
substrate for a highly sensitive picomole assay of ST6Gal1. Asialoglycopolypeptide was
regioselectively and quantitatively sialylated by catalytic reaction at the terminal Gal residue to
obtain  α2,6-sialoglycopolypeptide using ST6Gal1. The α2,6-sialoglycopolypeptide selectively
inhibited hemagglutination induced by Sambucus nigra (SNA) lectin, showing about 780-fold higher
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affinity than the control fetuin. Asialoglycopolypeptide and γ-polyglutamic acid did not affect SNA
lectin-mediated hemagglutination.
Conclusion: The recombinant ST6Gal1 from a silkworm expression system is useful for the
sialylation of asialoglycopeptide. The sialylated glycoprotein is a valuable tool for investigating the
molecular mechanisms of biological and physiological events, such as cell-cell recognition and viral
entry during infection.
Background
Sialic acids are distributed in a variety of glycolipids and
glycoproteins, often existing at the non-reducing termini
of carbohydrate chains. Sialic acids play important roles
in various biological and physiological events [1,2]. Sialic
acid is added to the terminal sugar of glycoproteins and
glycolipids by sialyltransferase (SiaT) enzymes. The sialic
acid that is added to a galactose (Gal) can be bound either
to the hydroxyl attached to carbon-3 of Gal to form an
α2,3 glycosidic linkage, or to the hydroxyl group attached
to carbon-6 to form an α2,6 glycosidic linkage. Weinstein
et al., [3] reported that the ST6Gal1 (EC 2. 4. 99. 1) gener-
ates a α2-6 linkage of sialic acid on the non-reducing, ter-
minal Galβ1-4GlcNAc residues of oligosaccharides and
glycoconjugates. Carbohydrate structures containing
Neu5Acα2,6 residues play critical roles in cell-cell recog-
nition and influenza virus infection [2].
Several systems for expression of recombinant proteins
are available, based on bacteria [4,5], yeast [6], insect [7-
9] and mammalian cells [10]. Since bacterial system
recombinant proteins are often insoluble and inactive,
alternative expression systems to obtain soluble and
active recombinant proteins are required. Insect cells
infected with recombinant baculovirus have been used for
high-level expression of recombinant proteins [9,11],
partly because these insect cells are capable of posttransla-
tional modifications similar to mammalian cells, and
because of high-level protein expression. Recombinant
baculoviruses are used to infect insect cells, such as Sf9
cells, and recombinant proteins are recovered from
infected cells. However, reactor performance, reactor
design, and medium development still require improve-
ments to increase the yield of recombinant proteins. For
example, serial passaging and preparation of a large
amount of recombinant baculovirus for infection of insect
cells are drawbacks of the baculovirus-insect cell expres-
sion system.
An alternative to the baculovirus expression system is silk-
worm larvae expression. Recently, a B. mori nucleopolyhe-
drovirus (BmNPV) bacmid system was developed [12] as
a shuttle vector that can be replicated in Escherichia coli, B.
mori cells and silkworm larvae. This enables more rapid
gene expression in silkworm than in conventional baculo-
virus expression systems. Moreover, a cysteine protease-
deficient BmNPV (BmNPV-CP-) bacmid [13] and both
cysteine protease- and chitinase-deficient BmNPV
(BmNPV-CP--Chi-) bacmids [14] have been developed for
the efficient production of gene products from silkworms.
Using this bacmid, human IgG [15], (pro)renin receptor
[16], and glycosyltransferase [17] were expressed success-
fully. The protein expression of these bacmids is higher
than that of wild-type BmNPV bacmid because of signifi-
cant decreases in silkworm liquefaction and proteolytic
degradation of expressed proteins.
In this study, we have successfully expressed a functional
rat ST6Gal1 in silkworm larvae, established efficient pro-
cedures for large-scale purification of the recombinant
enzyme. Furthermore, a novel synthetic substrate, fluores-
cently-labelled disaccharide glycoside was chemo-enzy-
matically synthesized for the ST6Gal1 assay.
Characterization and identification of N-glycans of the
purified recombinant rat ST6Gal1 from the silkworm lar-
val hemolymph are also reported. The recombinant
ST6Gal1 was used as a key enzyme for the synthesis of an
artificial sialoglycopolymer for potentially blocking influ-
enza virus infection.
Results
Expression of recombinant ST6Gal1 in bacmid-injected 
silkworm larval hemolymph
BmNPV-CP--Chi-/ST6Gal1 with bombyxin (bx) signal
peptides was constructed for secretion of ST6Gal1 into the
silkworm larval hemolymph. Hemolymph was sampled
at 1.5–7.5 d.p.i. and subjected to sialyltransferase activity
assay. Compound 3 was used as a novel synthetic sub-
strate for the fluorescence assay of sialyltransferase [see
Additional file 1]. We first investigated the action of
recombinant ST6Gal1 on 3  and CMP-Neu5Ac. When
recombinant ST6Gal1 was incubated with 3 and CMP-
Neu5Ac, it exclusively produced 5-(5-dimetylaminonaph-
thalene-1-sulfonyl-2-(2-aminoethoxy)) ethyl β-Neu5Ac
α2,6LacNAc (compound 5) as described in Additional file
1. The resulting compound 5 was used as an authentic
sample for enzyme assays. The ST6Gal1 assay used HPLC
to determine the fluorescence of 5 produced from 3 and
CMP-Neu5Ac by recombinant ST6Gal1 (Fig. 1).BMC Biotechnology 2009, 9:54 http://www.biomedcentral.com/1472-6750/9/54
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Sialylation of compound 3 as acceptor substrate by recombinant ST6Gal1 Figure 1
Sialylation of compound 3 as acceptor substrate by recombinant ST6Gal1. Detection of sialylated product 5 was 
performed by fluorescent-HPLC as described in Materials and methods.
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Rat ST6Gal1 was cloned as N-terminal His-, Strep- and
FLAG-tagged fusion proteins. When the three fusion pro-
teins were tested in the sialyltransferase activity assay,
FLAG-tagged ST6Gal1 (1960 mU/ml at 6.5 d.p.i.) had the
highest expression level, which was 1.8- or 4.1-hold
higher than that of Strep- or His-tagged ST6Gal1 (1083
mU/ml or 480 mU/ml at 6.5 d.p.i.), respectively (Fig. 2).
No activity was observed in mock-injected silkworm larval
hemolymph (Fig. 2).
Purification of recombinant FLAG-tagged ST6Gal1 
expressed in silkworm larval hemolymph
The purification of FLAG-tagged ST6Gal1 from 4.5 ml of
silkworm larval hemolymph is summarized in Table 1.
Twofold diluted hemolymph containing 9.0 units of
FLAG-tagged ST6Gal1 (0.016 U/mg protein) was satu-
rated with 25–70 ammonium sulphate and the resulting
precipitate protein was dissolved in 50 mM MOPS buffer
(pH 7.5) containing 150 mM NaCl and 0.02 Triton X-100.
In this fraction 7.2 units of FLAG-tagged ST6Gal1 (0.069
U/mg protein) were obtained with a yield of 80. After
removal of the ammonium sulphate with a Sephadex G-
25M PD-10 column, the enzyme was applied to an anti-
FLAG M2 column. Most of the sialyltransferase activity
adsorbed to the affinity column and was eluted by elution
with same buffer containing 100 μg/ml FLAG peptide. In
this final purification step, 5.8 units of FLAG-tagged
ST6Gal1 (2.6 U/mg protein) was obtained in a high yield
of 64 (over 150-fold) (Table 1). FLAG-tagged ST6Gal1
gave a single band on SDS-PAGE and isoelectric focusing
with an apparent mass of 40 kDa (Fig. 3) and a pI of 6.3
(data not shown). The MALDI-TOF mass spectrum gave a
main peak at m/z 45172 (Fig. 4).
Characterization of the purified recombinant FLAG-
tagged ST6Gal1
The optimum temperature of the purified enzyme was
determined by performing the standard assay in the range
4 to 80°C. Maximum activity was observed at 37°C for
the purified enzyme. The enzyme was stable below 20°C
but was rapidly inactivated at temperatures above 20°C.
The effect of pH on the activity of the purified enzyme was
studied in various buffers in the range of pH 2 to 10. The
optimum was pH 6.0. The purified enzyme was relatively
stable over a wide range of pH, and was especially stable
in the range of pH 5 to 9.
The kinetic parameters for the transfer reaction of fluores-
cently-labelled disaccharide glycosides by the purified
enzyme were determined by HPLC assays. The enzyme
acted preferentially on LacNAc glycoside over Lac glyco-
side. Thus, the kcat/Km value of LacNAc glycoside was 39-
fold higher than that of Lac glycoside (Table 2).
The detailed chromatogram and structure of the oligosac-
charides are shown in Fig. 5. Recombinant FLAG-tagged
ST6Gal1 produced non-reducing terminal α-mannosyl
groups with fucose (49.8) connected to GlcNAc near to
Asn. The yield of non-reducing terminal α-mannosyl sug-
ars was 94.1, including antennary sugars 10.9. An uniden-
tified oligosaccharide might be included among the
others (5.9) in Fig. 5B.
Synthesis of α2,6-sialoglycopolypeptide as glycoprotein 
mimetics using recombinant ST6Gal1
Asialoglycopolypeptide with a γ-PGA backbone was sia-
lylated to a sialoglycopolypeptide carrying
Neu5Acα2,6LacNAc, using recombinant ST6Gal1 from
silkworm hemolymph as previously described [18-20]
(Fig. 6). After separation with a Sephadex G-25M PD-10
column, the target glycopolypeptide was obtained. The
structures of the synthesized α2,6-sialoglycopolypeptide
were confirmed by 1H-, 13C-NMR and chemical analyses,
according [19]. The 1H-NMR spectrum also showed that
the degree of sialylation was quantitative from the integra-
tion data of the proton signals (Table 3) [21]. The degree
of substitution of neutral sugar derivatives (NS) and sialyl
sugar derivatives (Sia), based on the DP of γ-PGA was 100
(Table 3). These results indicated that the FLAG-tagged
ST6Gal1 regioselectively transfers Neu5Ac to the non-
reducing terminal of type II sugar chains, such as Galβ1-
4GlcNAc residues.
Hemagglutination inhibition assay with artificial 
sialoglycopolypeptides
Various substances carrying α2,6-sialooligosaccharide gly-
cosides are known to inhibit hemagglutination by bind-
Expression levels of recombinant ST6Gal1s in silkworm larval  hemolymph Figure 2
Expression levels of recombinant ST6Gal1s in silk-
worm larval hemolymph. Three types of BmNPV bac-
mids were injected directly into 1st day fifth-instar silkworm 
larvae. The expression of the fusion protein in silkworm lar-
vae was confirmed using a sialyltransferase activity assay.
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ing to SNA lectin [22]. We tested the inhibitory effect on
hemagglutination by SNA lectin of the synthesized α2,6-
sialoglycopolypeptide, using recombinant enzyme (Table
3). The α2,6-sialoglycopolypeptide prominently inhib-
ited hemagglutination by SNA lectin. The affinity of α2,6-
sialoglycopolypeptide for the SNA lectin was 780-fold
higher than that of the control fetuin. Both the asialoglyc-
opolypeptide and γ-polyglutamic acid itself did not
caused any SNA lectin-mediated hemagglutination (Table
3).
Discussion
Functional rat recombinant ST6Gal1 was expressed using
a bacmid system. The amount of recombinant protein
secreted from silkworm larvae was 2.0 U/ml (Fig. 2),
which was higher than that obtained from other expres-
sion systems. For example, the expression level of secreted
rat recombinant ST6Gal1 using Sf9 insect cells was
reported as 0.03 U/ml [23], mammalian ST6Gal1 using
yeast Pichia pastoris was reported as 0.3 × 10-3 U/ml [24]
and bacterial ST6Gal1 using Photobacterium damsela
JT0160 cell was reported at 0.55 U/ml [25]. In addition,
we produced various N-terminal-tagged ST6Gal1 using
our silkworm expression system. FLAG-tagged ST6Gal1
had a high expression level, which was 4.1-fold higher
than that of His-tagged ST6Gal1 (Fig. 2). Some investiga-
tors have reported the increase of expression levels of
recombinant proteins when N-terminal sequences were
changed [26-28]. Most likely, the polar character of the N-
terminal sequence is contributing to the expression level
of recombinant protein secreted from silkworm larvae.
The expressed FLAG-tagged ST6Gal1 was effectively puri-
fied by precipitation with ammonium sulphate followed
by affinity chromatography. The purified protein reached
200 μg/larva (Table 1). This highly purified enzyme might
be used for studies such as NMR or X-ray diffraction.
Recombinant protein produced by BmNPV-CP--Chi-/
FLAG-tagged ST6Gal1 with bx signal peptides infected
silkworm, was comparable to native rat liver ST6Gal1
with regard to substrate specificity and stability. FLAG-
tagged ST6Gal1 lacks an N-terminal hydrophobic region
found in the wild type protein, as previously reported by
[29]. The Km of the purified recombinant enzyme (0.92
mM) against Galβ1,4GlcNAcβ-R (compound 3, see Addi-
tional file 1) was similar to that those of rat liver ST6Gal1
[30] (Table 2). Furthermore, recombinant protein
expressed in silkworm is N-glycosylated. Most (94%) of
the N-glycan patterns of secreted recombinant proteins
produced in the silkworm larvae were nearly pauciman-
nosidic type structures, such as Man3GlcNAc2  or
Man2GlcNAc2 (± Fuc) (Fig. 5B). N-glycosylation is known
to be responsible for solubility and stability of glycopro-
teins. Recombinant protein expressed using silkworm lar-
vae has a high solubility in buffer. Moreover, no
significant loss of enzyme activity was observed upon
storage for 3 month at 4°C.
In addition, we also established a convenient synthesis for
fluorescently-labelled LacNAc glycoside as a high-sensitiv-
Table 1: Purification of a recombinant FLAG-tagged ST6Gal1 from silkworm larval hemolymph
Total activity (Ua) Total protein (mg) Specific activity (U/mg protein) Recovery yield (%) Purification (fold)
Crude enzyme
(larval hemolymph)
9.0 550.0 0.016 100 1
(NH4)2SO4 (25–70%) 7.2 105.0 0.07 80 4
Anti-FLAG M2 affinity 5.8 2.2 2.60 64 159
a One unit of activity is defined as 1 μmol/min of transfer product 5 formed from compound 3 as acceptor substrate under the condition of 37°C 
and pH 7.4. Product 5 and compound 3 were measured by HPLC-based assay described in Materials and Methods.
SDS-PAGE of recombinant FLAG-tagged ST6Gal1 expressed  in silkworm larval hemolymph Figure 3
SDS-PAGE of recombinant FLAG-tagged ST6Gal1 
expressed in silkworm larval hemolymph. Lane M, 
marker proteins, Lane 1, silkworm larval hemolymph (crude 
enzyme), Lane 2, ammonium sulphate precipitates, Lane 3, 
elution from anti-FLAG M2 affinity (purified recombinant 
enzyme).BMC Biotechnology 2009, 9:54 http://www.biomedcentral.com/1472-6750/9/54
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MALDI-TOF mass spectrometry of recombinant FLAG-tagged ST6Gal1 Figure 4
MALDI-TOF mass spectrometry of recombinant FLAG-tagged ST6Gal1. Each sample was dissolved in 0.1% TFA: 
acetonitrile (2:1 v/v) and mixed with the matrix solution (1:4 v/v). The mixture (1 μl) was put on a stainless target and crystal-
lized at room temperature. A mass calibration procedure was employed prior to the analysis of a sample using protein calibra-
tion standards I (Bruker Daltonics, Germany). The MALDI-TOF mass spectrum was acquired on an AutoFlex (Bruker 
Daltonics, Germany) and measured in linear mode using 20-kV ion acceleration without postacceleration. The spectrum was 
recorded at a detector voltage of 1.65 kV and was the averaged results of at least 300 laser shots. SDHB was used as the 
matrix.BMC Biotechnology 2009, 9:54 http://www.biomedcentral.com/1472-6750/9/54
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ity acceptor substrate for the assay of ST6Gal1 (see Addi-
tional file 1). LacNAc and lactose residues were
enzymatically connected to 2-(2-trifluoroasetami-
doethoxy)ethanol to produce the disaccharide glycosides.
Recently, we found that endo-β-glycosidase, a kind of cel-
lulase from T. reesei, catalyzes two reaction types, transgly-
cosylation and condensation [31]. This enzymatic
catalysis was harnessed for the synthesis of spacer-linked
LacNAc and lactose glycosides. The efficiency of the reac-
tion is not always high, but this method has two advan-
tages: first, the excess of unreacted LacNAc substrate,
which is a valuable substrate, is recovered by straightfor-
ward column chromatography and can be reutilized for
synthesis; and second, the O-glycosylation process stere-
ospecifically gives only the β-glycoside without the need
for protection or deprotection steps [32]. After deacyla-
tion of the resulting disaccharide glycosides, the amino
function was easily fluorescently-labelled. Especially, the
use of fluorescently-labelled LacNAc glycoside enabled
routine picomole assay of ST6Gal1. Furthermore, fluores-
cently-labelled glycosides with spacer structure containing
ether group, such as 2-(2-aminoethoxy)ethanol have an
extremely high solubility in water, as compared with alkyl
spacer, such as 5-amino-1-pentanol [32].
We have already reported that sialoglycopolypeptides
with γ-polyglutamic acid backbones can be used as a scaf-
fold in the synthesis of multivalent inhibitors of the influ-
enza viruses [19]. Thus, the recombinant enzyme was
applied to the conversion of asialoglycopolypeptide to
α2,6-sialoglycopolypeptide. The asialoglycopolypeptide
was quantitatively sialylated to obtain sialoglycopolypep-
tide carrying Neu5Acα2,6LacNAc residues by recom-
binant enzyme (Fig. 6). We tested the inhibitory effect of
the artificial α2,6-sialoglycopolypeptide synthesized with
recombinant enzyme on hemagglutination by SNA lectin,
as a model of human influenza viruses. The α2,6-
sialoglycopolypeptide prominently inhibited hemaggluti-
nation by SNA lectin with a very low concentration (IC50
0.94 nM) (Table 3). The α2,6-sialoglycopolypeptide dis-
played 780-fold higher affinities for the SNA hemaggluti-
nins relative to the control fetuin (IC50 730 nM).
Conclusion
The ST6Gal1 was purified, generating 2.2 mg purified
fusion protein from only 11 silkworm larvae, with a recov-
ery yield of 64%. The N-glycan patterns of purified
ST6Gal1 were found to be approximately paucimanno-
sidic type. The acceptor substrate specificity of the enzyme
was similar to that of rat liver ST6Gal1. By catalytic reac-
tion of this ST6Gal1, asialoglycopolypeptide was regiose-
lectively and quantitatively sialylated to the terminal Gal
residue to obtain α2,6-sialoglycopolypeptide. The α2,6-
sialoglycopolypeptide selectively inhibited hemagglutina-
tion induced by SNA lectin, showing about 780-fold
higher affinity than the control fetuin. This recombinant
ST6Gal1 obtained using a silkworm expression system is
a valuable tool for investigating the molecular mecha-
nisms of biological and physiological events, such as cell-
cell recognition and viral infections.
Methods
Construction of recombinant BmNPV bacmids
Rat ST6Gal1 (Δ1–189, lacking the N-terminal hydropho-
bic region) gene [29] was amplified from a rat liver cDNA
library using the ST6Gal1 primer set (Table 4). Polymer-
ase chain reaction (PCR) was performed according to the
supplier's directions. All of the amplified PCR products
were purified using a GFX PCR purification kit (Biocom-
pare Inc., San Francisco, CA), digested with a BamHI and
EcoRI restriction kit and ligated using T4 ligase into
pBlueBacHis2 (Invitrogen, Carlsbad, CA, USA) digested
with BamHI and EcoRI (pBH/ST6Gal1).
In order to secrete expressed protein into the hemolymph
of silkworm larvae, the signal sequence from bombyxin
(bx) was added to ST6Gal1. Using pBH/ST6Gal1 as a tem-
plate, PCR was carried out with CACC-bx forward and
ST6Gal1 reverse primers (Table 4) with these conditions:
5 min at 94°C, 30 cycles at 94°C for 30 sec, 55°C for 40
sec, and 72°C for 1.5 min, followed by a final extension
at 72°C for 5 min. The amplified DNA fragment was des-
ignated His-tagged ST6Gal1. Similarly, Strep-tagged and
FLAG-tagged ST6Gal1 genes were amplified using the
CACC-bx-Strep-ST6Gal1 and CACC-bx-FLAG-ST6Gal1
primer sets (Table 4). Using BmNPV bacmid-CP--Chi-/bx-
His-ST6Gal1 as a template, PCR was performed according
to the supplier's directions. The DNA fragments were
cloned into pENTR using pENTR Directional TOPO Clon-
ing Kits (Invitrogen), resulting in pENTR/bx-His-, Strep-
and FLAG-ST6Gal1. These were cloned into pDEST8 using
the Gateway system (Invitrogen), resulting in pDEST8/bx-
Table 2: Kinetic parameter for transfer reaction of acceptor substrates
Sugar moiety Km (mM) Vmax (mM/min) kcat (s-1)a kcat/Km (mM-1s-1)
LacNAc β-Rb 0.92 0.17 1.13 1.23
Lactose β-R 2.80 0.013 0.087 0.031
a kcat = Vmax/E, where E denote amount of enzyme.
b R = 5-(5-Dimetylaminonaphthalene-1-sulfonyl-2-(2-aminoethoxy))ethylBMC Biotechnology 2009, 9:54 http://www.biomedcentral.com/1472-6750/9/54
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N-Glycosylation profile of recombinant FLAG-tagged ST6Gal1 and proposed structure of PA-oligosaccharides Figure 5
N-Glycosylation profile of recombinant FLAG-tagged ST6Gal1 and proposed structure of PA-oligosaccharides. 
A, N-Glycosylation profile of recombinant FLAG-tagged ST6Gal1 on an ODS column. The epidemic by-products of pyridylam-
ination reaction are indicated with prime, e.g. b'. B, The proposed structure of PA-oligosaccharides obtained using recom-
binant FLAG-tagged ST6Gal1 expressed in silkworm larval hemolymph.
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His-, Strep- and FLAG-ST6Gal1. To decrease proteolytic
degradation of expressed ST6Gal1, a cysteine protease-
and chitinase-deficient B. mori multiple nucleopolyhedro-
virus (BmNPV-CP--Chi-) bacmid [14] was used. The plas-
mid was transformed into E. coli DH10BacBm-CP--Chi-,
cultivated on LB plates containing kanamycin, gentamy-
cin, tetracycline, chloramphenicol, 5-bromo-4-chloro-3-
indolyl-β-D-galactopyranoside (X-gal) and isopropyl β-D-
1-thiogalactopyranoside (IPTG). White colonies were
picked, and positive clones were selected.
Expression of ST6Gal1 in silkworm larvae
BmNPV bacmids DNA were injected directly into 1st day
fifth-instar hybrid Kinsyu × Syowa silkworm larvae
(Ehime Sansyu, Co. Ltd., Yahatahama, Japan). BmNPV
bacmid (100 ng/μl) and 10 1,2-dimyristyloxypropyl-3-
dimethyl-hydroxy ethyl ammonium bromide (DMRIE)-C
reagent (Invitrogen) were dissolved in 10 mM PBS (pH
7.4) and left to stand at room temperature for 45 min.
Then, 40 μl of the mixture was injected into dorsal of the
larvae using a syringe with a 26-gauge bevelled needle.
The larvae were reared on an artificial diet (Silkmate 2S,
Nihon Nosan Co. Ltd., Yokohama, Japan) at 27 ± 1°C.
The expression of the fusion protein in silkworm larvae
was confirmed using a sialyltransferase activity assay.
Sample preparation for assay
At 1.5–7.5 days postinjection (d.p.i.) the larval hemol-
ymph was harvested by cutting a caudal leg in a tube con-
taining 1 mM 1-phenyl-2-thiourea, and centrifuged at
8000 rpm at 4°C for 10 min. The supernatant samples
were immediately frozen at -80°C for future analysis.
Sialyltransferase Assay
CMP-β-Neu5Ac (10 mM), 5-(5-dimethylaminonaphtha-
lene-1-sulfonyl-2-(2-aminoethoxy))ethyl  β-LacNAc
(compound 3, see Additional file 1) (5 mM), MnCl2 (2.5
mM) and BSA (2.5 mM) were dissolved in 50 mM MOPS
(pH 7.4) followed by 13 μl of enzyme solution (total vol-
ume 20 μl) at 37°C. The reaction was initiated by addi-
tion of ST6Gal1. At each sample time, 2 μl of the reaction
mixture was added to 98 μl of 25% acetonitrile. After fil-
tration through a 0.45 μm nitrocellulose filter (Millipore,
Bedford, MA) the filtrates were analyzed by HPLC using a
TSK-gel ODS 80TsQA (4.6 × 250 mm, TOSOH Co.) col-
umn and eluted with 25% acetonitrile. A JASCO LC-2000
plus HPLC system equipped with an FP-2020 plus fluores-
cence detector (excitation, 330 nm; emission, 520 nm),
operating isocratically at 1.0 ml/min at a column temper-
ature of 40°C, was used. One unit of enzyme activity was
defined as the amount of enzyme capable of catalyzing
the transfer of 1 μmol of Neu5Ac per minute. The amount
Table 3: Inhibition of SNA lectin hemagglutination by the 
artificial sialoglycopolypeptide as glycoprotein mimetics
Entry compounds kDa NSd (%) Siah (%) IC50
i (nM)
γ-Polyglutamic acid (γ-PGA) 990a - - N.E.j
Asialoglycopolypeptide 2100b 40e (33f)- N . E .
α2,6-Sialoglycopolypeptide 2800b 0 40 (39) 0.94
Fetuin (Sialoglycoprotein) 48c N.D.g (13.5) 730
a Provided by Meiji Seika Kaisha, Ltd. (Tokyo, Japan).
b Estimated from degree of substitution of asialo- or sialo-sugar 
derivatives based on DP of γ-PGA as 100%, which was calculated from 
1H NMR data at 25°C.
c Neutral sugar derivatives substituted
d Degree of substitution of asialo- or sialo-sugar derivatives based on 
DP of γ-PGA as 100%, which was calculated from 1H NMR data at 
25°C.
e Degree of substitution of asialo- or sialo-sugar derivatives based on 
DP of γ-PGA as 100%, which was calculated from two types of HPLC 
analys (ABEE and DMB methods). All data normalized to those of 1H 
NMR.
f Not determined
g Sialyl sugar derivatives substituted (= Sia contents)
h Minimum concentrations required for complete inhibition of 
hemagglutination
i No effect means that inhibitory effect was not observed up to 200 
nM of γ-PGA or asialoglycopolypeptide Enzymatic synthesis of the artificial Sialoglycopolypeptide Figure 6
Enzymatic synthesis of the artificial Sialoglycopoly-
peptide. α2,6-Sialoglycopolypeptide was enzymatically syn-
thesized from asialoglycopolypeptide using recombinant 
ST6Gal1. A mixture containing 5.0 mg of asialoglycopolypep-
tide, 16.0 mM CMP-β-Neu5Ac, 80 mU/ml of the purified 
FLAG-tagged ST6Gal1, 2.5 mM MnCl2, 0.1 BSA and 10 U/ml 
of calf intestine alkaline phosphatase (Boehringer-Mannheim, 
Mannheim, Germany) in 50 mM MOPS buffer (pH 7.4) was 
incubated at 37°C for 48 h in a total volume of 1.0 ml. After 
heating at 100°C followed by centrifugation, the supernatant 
from the reaction mixture was directly loaded onto a Sepha-
dex G-25M PD-10 column equilibrated with 100 mM PBS 
(pH 7.4).
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of protein was determined using a Bio-Rad protein assay
kit.
Purification of FLAG-tagged ST6Gal1 by affinity 
chromatography
All purification steps were performed at 4°C unless other-
wise stated. At 6.5 d.p.i. the larval hemolymph was col-
lected by cutting a caudal leg into a tube containing 1 mM
1-phenyl-2-thiourea, and centrifuging at 8000 rpm at 4°C
for 10 min. The silkworm larval hemolymph (4.5 ml, 9.0
U) was twofold diluted with 50 mM MOPS buffer (pH
7.5) containing 150 mM NaCl and 0.02% Triton X-100.
Proteins were precipitated in 25 ammonium sulphate.
After centrifugation, solid ammonium sulphate was
added to the supernatant to 70% saturation. The precipi-
tate was dissolved with same buffer (6.9 ml, 7.2 U). After
desalting with a Sephadex G-25M PD-10 column (Amer-
sham Biosciences Corp., NJ, USA), the solution was
applied to an anti-FLAG M2 (7 ml) column. The column
was washed with 10 volumes of binding buffer 50 mM
Tris-HCl buffer (pH 8.0) containing 150 mM NaCl and
0.02 Triton X-100, followed by 10 volumes of elute buffer
50 mM Tris-HCl buffer (pH 8.0) containing 150 mM
NaCl, 0.02 Triton X-100 and 100 μg/ml FLAG peptide.
Eluted fractions containing the purified enzyme were col-
lected, dialyzed against 50 mM MOPS buffer (pH 7.5)
containing 150 mM NaCl and 0.02 Triton X-100, and
stored at 4°C (2.5 ml, 5.8 U) (Table 1).
Characterization of recombinant ST6Gal1 expressed in 
silkworm larva
SDS-PAGE and Isoelectric Focusing
SDS-polyacrylamide gel electrophoresis (SDS-PAGE,
13%) was done by the method of Laemmli [33]. Samples
were heated in the presence or absence of 2-mercaptoeth-
anol at 100°C for 10 min. Gels were stained with
Coomassie Brilliant Blue. The molecular masses on SDS-
PAGE were estimated using recombinant ladder markers
(10 to 100 kDa; XL-Ladder Low; APRO Life Science Insti-
tute, Inc., Japan). Isoelectric focusing (PhastGel IEF, pH
3–9) was done in a Phastsystem (GE Healthcare, UK). The
pI standards (Pharmacia) used were trypsinogen (pI
9.30), lentil lectin basic band (8.65), lentil lectin acidic
band (8.15), myoglobin basic band (7.35), myoglobin
acidic band (6.85), human carbonic anhydrase B (6.55),
bovine carbonic anhydrase B (5.85), β-lactoglobulin A
(5.20), soybean trypsin inhibitor (4.55), and amyloglu-
cosidase (3.50).
Molecular mass
The molecular mass of FLAG-tagged ST6Gal1 was deter-
mined by SDS-PAGE and MALDI-TOF mass spectroscopy.
The MALDI-TOF mass spectrum was acquired on an
AutoFlex (Bruker Daltonics, Germany) and measured in
linear mode using 20-kV ion acceleration without postac-
celeration. The spectrum was recorded at a detector volt-
age of 1.65 kV and was the averaged results of at least 300
laser shots. SDHB was used as the matrix. Each sample
was dissolved in 0.1% TFA: acetonitrile (2:1 v/v) and
mixed with the matrix solution (1:4 v/v). The mixture (1
μl) was put on a stainless target and crystallized at room
temperature. A mass calibration procedure was employed
prior to the analysis of a sample using protein calibration
standards I (Bruker Daltonics, Germany).
Effect of temperature and pH on enzyme activity and stability
The effect of temperature on SiaT activity was determined
by incubating the purified enzyme with donor (CMP-
Neu5Ac) and acceptor substrate (compound 3) in 50 mM
MOPS buffer (pH 7.4) containing MnCl2 and BSA for 15
min at different temperatures ranging from 4 to 80°C.
Thermal stability of the enzyme was determined by assay-
ing for residual enzyme activity after incubation at various
temperatures for 30 min without substrates.
Table 4: Primers used for the cloning of rat ST6Gal1
Primers Sequence (5'→3')
Forward primer
CACC-bx CACCATGAAGATACTCCTTGCTATTGCATTAATGTTG
TCAACAGTAATGTGGGTGTCAACACAACCGCGGGGTT
CTCATCATC
ST6Gal1 TATGGATCCGAGCAAGCAAGACCCTAAGGAAGACATT
CACC-bx-Strep-ST6Gal1 CACCATGAAGATACTCCTTGCTATTGCATTAATGTTG
TCAACAGTAATGTGGGTGTCAACACCATGGAGCCATC
CGCAGTTTGAAAAGAGCAAGCAAGACCCTAAGGAAG
CACC-bx-FLAG-ST6Gal1 CACCATGAAGATACTCCTTGCTATTGCATTAATGTTG
TCAACAGTAATGTGGGTGTCAACACCAGACTACAAGG
ATGACGATGACAAGAGCAAGCAAGACCCTAAGGAAG
Reverse primer
ST6Gal1 TATGAATTCTCAACAACGAATGTTCCGGAAGCCAGABMC Biotechnology 2009, 9:54 http://www.biomedcentral.com/1472-6750/9/54
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The optimal pH of SiaT activity was examined in the range
of pH 2 to 10 under standard assay conditions using 50
mM of glycine-HCl buffer (pH 2 to 3), citrate buffer (pH
3 to 5), MES buffer (pH 5 to 6), MOPS buffer (pH 6 to 8),
Tris-HCl buffer (pH 8 to 9) and glycine-NaOH buffer (pH
9 to 10). The effect of pH on ST6Gal1 stability was deter-
mined using the same buffer system in the range of pH 2
to 10. The enzyme solution was incubated at various pH
values for 30 min at 4°C without substrates. The remain-
ing enzyme activity was then measured at 37°C against
donor (CMP-Neu5Ac) and acceptor substrate (compound
3) in 50 mM MOPS buffer (pH 7.4) containing MnCl2 and
BSA.
Kinetic parameters for the transfer reaction to acceptor substrates
CMP-β-Neu5Ac (10 mM), 5-(5-dimethylaminonaphtha-
lene-1-sulfonyl-2-(2-aminoethoxy))ethyl  β-LacNAc or -
lactoside (compounds 3 or 4, see Additional file 1)(0.156
– 5.0 mM), MnCl2 (2.5 mM) and BSA (2.5 mM) were dis-
solved in 50 mM MOPS (pH 7.4) followed by addition of
80 μl of purified FLAG-tagged ST6Gal1 (total volume 100
μl) to initiate the reaction at 37°C. The reaction was initi-
ated by addition of 2.5 μM of ST6Gal1. Samples (20 μl)
were taken at intervals (0, 1, 2, 3, 4, 5 min) during the
incubation, and inactivated with 80 μl of 25 acetonitrile.
The amount of transfer product formed from initial sub-
strates at an early stage was analyzed by HPLC. Quantifi-
cation of products was as described above, and initial
velocities (υ) were obtained directly from the initial
slopes of the time-course plots. Six different substrate con-
centrations (0.156 – 5.0 mM) were used per experiment.
The Vmax and Km values for synthetic acceptor substrates
were calculated from the Lineweaver-Burk plot by the least
squares method. Catalytic constant (kcat) of ST6Gal1 was
defined as dividing Vmax by amount of ST6Gal1.
Characterization of N-linked glycan by HPLC mapping
The experimental procedures used, including the chroma-
tographic and mass spectrometric conditions, have been
described previously [34-36], with slight modifications in
the preparation of 2-aminopyridine derivatives of the N-
glycans. The purified FLAG-tagged ST6Gal1 (2.0 mg) was
proteolyzed with trypsin and chymotrypsin, and further
digested with PNGase F (New England Biolabs, MA, USA)
to release N-glycans. After removal of the peptides by Sep-
Pack reversed-phase cartridges (Waters, MA, USA), the
reducing ends of the N-glycans were derivatized with 2-
aminopyridine (Wako, Osaka, Japan). The mixture of the
2-aminopyridine-derivatived (PA) glycans was separated
by an octadecyl silica (ODS) column (Shimadzu, Kyoto,
Japan) and the elution time recorded which represents the
glucose unit (GU) value. The individual fractions were
subjected to matrix-assisted laser desorption/ionization-
time of flight mass spectrometry (MALDI-TOF MS). The
identification of N-glycan structures was based on their
GUs and mass values in comparison with PA-glycans in
the web application GALAXY database http://www.glyco
analysis.info/galaxy2/ENG/systemin1.jsp[37]. The PA-
oligosaccharides were subject to matrix-assisted laser des-
orption/ionization time of flight mass spectrometry
(MALDI-TOF-MS) analyses and co-chromatographed
with reference to PA-oligosaccharides on the columns to
confirm their identities.
Synthesis of sialoglycopolypeptides as glycoprotein 
mimetics using recombinant ST6Gal1
α2,6-Sialoglycopolypeptide was enzymatically synthe-
sized from asialoglycopolypeptide [19] using recom-
binant ST6Gal1. A mixture containing 5.0 mg of
asialoglycopolypeptide, 16.0 mM CMP-β-Neu5Ac, 80
mU/ml of the purified FLAG-tagged ST6Gal1, 2.5 mM
MnCl2, 0.1 BSA and 10 U/ml of calf intestine alkaline
phosphatase (Boehringer-Mannheim, Mannheim, Ger-
many) in 50 mM MOPS buffer (pH 7.4) was incubated at
37°C for 48 h in a total volume of 1.0 ml. After heating at
100°C followed by centrifugation, the supernatant from
the reaction mixture was directly loaded onto a Sephadex
G-25M PD-10 column equilibrated with 100 mM PBS
(pH 7.4). The high-molecular-weight fraction was dia-
lyzed against distilled water for 3 days and lyophilized to
yield α2,6-sialoglycopolypeptide (6.0 mg) (Fig. 2).
Hemagglutination inhibition assay
The hemagglutination inhibition assay was carried out
using 96-well microtiter plates as described previously
[38]. Phosphate-buffered saline (PBS, pH 6.5) was used as
a dilution buffer. SNA (EY Laboratories Inc., San Mteo,
CA, USA) lectin suspension (22 hemagglutination titres in
0.025 ml of PBS) was added to each well containing the
artificial glycopolypeptides (200 to 0.024 μnM) or fetuin
(250 to 0.122 M) in a twofold serial dilution in dilution
buffer. After incubation for 1 h at 4°C, 0.05 ml of 0.6 (v/
v) guinea-pig suspension erythrocytes was added to the
plates, and allowed to settle for 2 h at 4°C. The maximum
dilution of the samples showing complete inhibition of
hemagglutination was defined as the hemagglutination
inhibition titer.
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